{{Rsnum
|rsid=6013382
|Gene=ZFP64
|Chromosome=20
|position=52086094
|Orientation=plus
|GMAF=0.4536
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ZFP64
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 28.3 | 49.6 | 22.1
| HCB | 48.2 | 46.7 | 5.1
| JPT | 43.8 | 44.6 | 11.6
| YRI | 18.4 | 46.3 | 35.4
| ASW | 24.6 | 43.9 | 31.6
| CHB | 48.2 | 46.7 | 5.1
| CHD | 50.0 | 38.9 | 11.1
| GIH | 28.7 | 47.5 | 23.8
| LWK | 25.5 | 50.0 | 24.5
| MEX | 27.6 | 46.6 | 25.9
| MKK | 39.1 | 41.7 | 19.2
| TSI | 33.3 | 44.1 | 22.5
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs6013382
|PubMedID=17362836
|Condition=Amyotrophic lateral sclerosis
|Gene=ZFP64
|Risk Allele=
|pValue=5.00E-006
|OR=1.43
|95CI=1.11-1.67
}}

{{PharmGKB
|RSID=rs6013382
|Name_s=
|Gene_s=ZFP64
|Feature=
|Evidence=PubMed ID:17362836; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data (Initial Sample Size: 276 cases, 276 controls; Replication Sample Size: NR). This variant is associated with Amyotrophic lateral sclerosis.
|Drugs=
|Drug Classes=
|Diseases=Amyotrophic Lateral Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356534
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6013382
|overall_frequency_n=60
|overall_frequency_d=124
|overall_frequency=0.483871
|n_genomes=39
|n_genomes_annotated=0
|n_haplomes=56
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}